CEOInterviews.AI
Verified executive transcripts, quotes, and interview insights from Seaport Therapeutics leadership.
Neuropsychiatric drug developer founded by PureTech, launched with a $100 million Series A. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Seaport Therapeutics executive via our platform or API.